Cargando…
Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
The prevalence of acinetobacter baumannii (AB) as a cause of hospital infections has been rising. Unfortunately, emerging colistin resistance limits therapeutic options and affects the outcome. The aim of the study was to confirm our clinically-driven hypothesis that intensive care unit (ICU) patien...
Autores principales: | Papathanakos, Georgios, Andrianopoulos, Ioannis, Papathanasiou, Athanasios, Priavali, Efthalia, Koulenti, Despoina, Koulouras, Vasilios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074815/ https://www.ncbi.nlm.nih.gov/pubmed/32093299 http://dx.doi.org/10.3390/microorganisms8020287 |
Ejemplares similares
-
Acinetobacter baumannii Bloodstream Infections in the COVID-19 Era: A Comparative Analysis between COVID-19 and Non-COVID-19 Critically Ill Patients
por: Andrianopoulos, Ioannis, et al.
Publicado: (2023) -
Clinical Sepsis Phenotypes in Critically Ill Patients
por: Papathanakos, Georgios, et al.
Publicado: (2023) -
Adapting in the COVID-19 Era
por: Papathanakos, Georgios, et al.
Publicado: (2020) -
Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report
por: Garcia Casallas, Julio Cesar, et al.
Publicado: (2019) -
Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)